HEADER LIGASE 01-DEC-06 2E41 TITLE CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII TITLE 2 COMPLEXED WITH THE REACTION PRODUCT ANALOG BIOTINOL-5'-AMP, MUTATIONS TITLE 3 R48A AND K111A COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIOTIN--[ACETYL-COA-CARBOXYLASE] LIGASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BIOTIN PROTEIN LIGASE; COMPND 5 EC: 6.3.4.15; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 70601; SOURCE 4 STRAIN: OT3; SOURCE 5 GENE: BPL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: (DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 11A KEYWDS BIOTIN BIOSYNTHESIS, DIMER, STRUCTURAL GENOMICS, NPPSFA, NATIONAL KEYWDS 2 PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN KEYWDS 3 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR B.BAGAUTDINOV,Y.MATSUURA,S.BAGAUTDINOVA,N.KUNISHIMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 5 25-OCT-23 2E41 1 REMARK REVDAT 4 10-NOV-21 2E41 1 REMARK SEQADV REVDAT 3 13-JUL-11 2E41 1 VERSN REVDAT 2 27-MAY-08 2E41 1 JRNL VERSN REVDAT 1 05-JUN-07 2E41 0 JRNL AUTH B.BAGAUTDINOV,Y.MATSUURA,S.BAGAUTDINOVA,N.KUNISHIMA JRNL TITL PROTEIN BIOTINYLATION VISUALIZED BY A COMPLEX STRUCTURE OF JRNL TITL 2 BIOTIN PROTEIN LIGASE WITH A SUBSTRATE JRNL REF J.BIOL.CHEM. V. 283 14739 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18372281 JRNL DOI 10.1074/JBC.M709116200 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 42972 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2122 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 210 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3623 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 501 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.13000 REMARK 3 B22 (A**2) : -7.31000 REMARK 3 B33 (A**2) : 8.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.62000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2E41 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000026197. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42972 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 41.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.31300 REMARK 200 R SYM FOR SHELL (I) : 0.27500 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1WQW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, ACETATE, NAOH, BIOTINOL-5' REMARK 280 -AMP, PH 5.2, MICROBATCH, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.41250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG B 233 REMARK 465 PHE B 234 REMARK 465 LEU B 235 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 101 NE1 TRP A 101 CE2 0.117 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 120 64.56 -168.95 REMARK 500 VAL A 132 -75.97 -111.35 REMARK 500 SER A 199 149.41 179.50 REMARK 500 ASP A 206 -179.14 177.95 REMARK 500 ASP A 229 22.82 86.12 REMARK 500 LEU B 49 -125.95 50.38 REMARK 500 VAL B 132 -76.86 -109.53 REMARK 500 ASP B 206 -176.81 176.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTX A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTX B 1302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WQW RELATED DB: PDB REMARK 900 THE APO-PROTEIN COMPLEXED WITH BIOTINYL-5'-AMP REMARK 900 RELATED ID: 2E3Y RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ADENOSINE AND BIOTIN REMARK 900 RELATED ID: PHO001000147.22 RELATED DB: TARGETDB DBREF 2E41 A 1 235 UNP O57883 O57883_PYRHO 1 235 DBREF 2E41 B 1 235 UNP O57883 O57883_PYRHO 1 235 SEQADV 2E41 ALA A 48 UNP O57883 ARG 48 ENGINEERED MUTATION SEQADV 2E41 ALA A 111 UNP O57883 LYS 111 ENGINEERED MUTATION SEQADV 2E41 ALA B 48 UNP O57883 ARG 48 ENGINEERED MUTATION SEQADV 2E41 ALA B 111 UNP O57883 LYS 111 ENGINEERED MUTATION SEQRES 1 A 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 A 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 A 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 A 235 ASP LYS GLN THR MET GLY HIS GLY ALA LEU ASN ARG LYS SEQRES 5 A 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 A 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 A 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 A 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 A 235 VAL LEU VAL ASN TYR LYS ALA ILE ALA GLY VAL LEU VAL SEQRES 10 A 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 A 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 A 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 A 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 A 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 A 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 A 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 A 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 A 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 A 235 LEU SEQRES 1 B 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 B 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 B 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 B 235 ASP LYS GLN THR MET GLY HIS GLY ALA LEU ASN ARG LYS SEQRES 5 B 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 B 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 B 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 B 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 B 235 VAL LEU VAL ASN TYR LYS ALA ILE ALA GLY VAL LEU VAL SEQRES 10 B 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 B 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 B 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 B 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 B 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 B 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 B 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 B 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 B 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 B 235 LEU HET BTX A1301 37 HET BTX B1302 37 HETNAM BTX ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY- HETNAM 2 BTX TETRAHYDROFURAN-2-YL)METHYL 5-((3AS,4S,6AR)-2-OXO- HETNAM 3 BTX HEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTYL HETNAM 4 BTX HYDROGEN PHOSPHATE HETSYN BTX BIOTINOL-5-AMP FORMUL 3 BTX 2(C20 H30 N7 O8 P S) FORMUL 5 HOH *501(H2 O) HELIX 1 1 SER A 21 SER A 29 1 9 HELIX 2 2 GLY A 47 ARG A 51 5 5 HELIX 3 3 PRO A 71 PRO A 76 5 6 HELIX 4 4 LYS A 77 PHE A 93 1 17 HELIX 5 5 SER A 142 GLY A 148 1 7 HELIX 6 6 PRO A 152 ASN A 174 1 23 HELIX 7 7 MET A 176 MET A 186 1 11 HELIX 8 8 SER B 21 SER B 29 1 9 HELIX 9 9 PRO B 71 PRO B 76 5 6 HELIX 10 10 LYS B 77 PHE B 93 1 17 HELIX 11 11 SER B 142 GLY B 148 1 7 HELIX 12 12 PRO B 152 ASN B 174 1 23 HELIX 13 13 MET B 176 ASN B 185 1 10 SHEET 1 A14 ARG A 98 LYS A 100 0 SHEET 2 A14 ASP A 104 VAL A 107 -1 O LEU A 106 N ARG A 98 SHEET 3 A14 LYS A 110 GLY A 119 -1 O ILE A 112 N VAL A 105 SHEET 4 A14 ILE A 124 LEU A 130 -1 O VAL A 125 N GLU A 118 SHEET 5 A14 LEU A 60 LEU A 66 -1 N LEU A 60 O LEU A 130 SHEET 6 A14 THR A 35 ALA A 39 -1 N ILE A 37 O SER A 63 SHEET 7 A14 ARG A 12 PHE A 16 1 N ILE A 14 O VAL A 36 SHEET 8 A14 ARG B 12 PHE B 16 -1 O TYR B 15 N VAL A 13 SHEET 9 A14 VAL B 36 ALA B 39 1 O VAL B 36 N ILE B 14 SHEET 10 A14 LEU B 60 LEU B 66 -1 O SER B 63 N ILE B 37 SHEET 11 A14 LYS B 123 LEU B 130 -1 O ILE B 124 N LEU B 66 SHEET 12 A14 LYS B 110 LYS B 120 -1 N GLU B 118 O VAL B 125 SHEET 13 A14 ASP B 104 VAL B 107 -1 N VAL B 105 O ILE B 112 SHEET 14 A14 ARG B 98 LYS B 100 -1 N ARG B 98 O LEU B 106 SHEET 1 B 5 VAL A 222 VAL A 225 0 SHEET 2 B 5 LEU A 213 ARG A 216 -1 N LEU A 213 O VAL A 225 SHEET 3 B 5 SER A 199 ILE A 207 -1 N ASP A 206 O ILE A 214 SHEET 4 B 5 ARG A 191 LEU A 195 -1 N VAL A 192 O GLY A 202 SHEET 5 B 5 SER A 231 PHE A 234 -1 O ARG A 233 N LYS A 193 SHEET 1 C 5 VAL B 222 VAL B 225 0 SHEET 2 C 5 LEU B 213 ARG B 216 -1 N LEU B 213 O VAL B 225 SHEET 3 C 5 PHE B 200 ILE B 207 -1 N ASP B 206 O ILE B 214 SHEET 4 C 5 VAL B 190 ILE B 194 -1 N VAL B 192 O GLY B 202 SHEET 5 C 5 VAL B 230 SER B 231 -1 O SER B 231 N LYS B 193 CISPEP 1 TRP A 101 PRO A 102 0 -4.10 CISPEP 2 TRP B 101 PRO B 102 0 0.05 SITE 1 AC1 25 SER A 21 THR A 22 ASN A 23 GLN A 42 SITE 2 AC1 25 GLY A 45 HIS A 46 GLY A 47 ALA A 48 SITE 3 AC1 25 ARG A 51 LYS A 52 TRP A 53 GLU A 54 SITE 4 AC1 25 LEU A 62 ASN A 103 GLY A 114 ILE A 128 SITE 5 AC1 25 GLY A 129 ASN A 131 ALA A 140 HOH A1403 SITE 6 AC1 25 HOH A1426 HOH A1465 HOH A1500 HOH A1509 SITE 7 AC1 25 HOH A1531 SITE 1 AC2 23 SER B 21 THR B 22 ASN B 23 GLN B 42 SITE 2 AC2 23 GLY B 45 HIS B 46 GLY B 47 ALA B 48 SITE 3 AC2 23 ARG B 51 LYS B 52 TRP B 53 GLU B 54 SITE 4 AC2 23 LEU B 62 ASN B 103 ASP B 104 GLY B 114 SITE 5 AC2 23 ILE B 128 GLY B 129 ASN B 131 PRO B 137 SITE 6 AC2 23 ALA B 140 HOH B1390 HOH B1425 CRYST1 38.248 82.825 72.711 90.00 101.61 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026145 0.000000 0.005372 0.00000 SCALE2 0.000000 0.012074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014040 0.00000